54211 studies found for:    Open Studies
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting A Study of the Safety and Efficacy of Bimatoprost Ophthalmic Solution in Paediatric Patients With Glaucoma
Condition: Glaucoma
Interventions: Drug: bimatoprost ophthalmic solution formulation A;   Drug: timolol ophthalmic solution;   Drug: bimatoprost vehicle
2 Not yet recruiting Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492
Conditions: Adrenocortical Adenoma;   Sarcoma, Endometrial Stromal
Interventions: Procedure: MRI;   Procedure: Dexamethasone Supression Test;   Procedure: Sonogram;   Procedure: Biopsy;   Drug: BGG492
3 Unknown  Pelvic Examination in Pregnancy
Conditions: Early Pregnancy Bleeding;   Abdominal Pain
Interventions: Procedure: No Pelvic Exam;   Procedure: Pelvic Examination
4 Unknown  Thalidomide, Cyclophosphamide, Oral Idarubicin and Dexamethasone (T-CID) in Patients With Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: thalidomide;   Drug: idarubicin
5 Not yet recruiting A Study of Safety and Pharmacokinetics of Volitinib With Docetaxel in Patients With Advanced Gastric Cancer
Condition: Gastric Cancer
Interventions: Drug: Volitinib;   Drug: Docetaxel
6 Recruiting Salvage Chemotherapy for Poor Prognosis Germ Cell Tumors
Condition: Germ Cell Tumor
Interventions: Drug: Bevacizumab;   Drug: ICE chemotherapy regimen
7 Recruiting Iron Depletion and Replacement in Blood Donors
Condition: Anemia
Interventions: Dietary Supplement: Ferrous gluconate 325mg;   Behavioral: Nutrition counseling
8 Unknown  Efficacy of R-Pdf/Gbb in Healing Wounds Caused by Third Degree Thermal and Electrical Burns
Conditions: Burns;   Electric Burns
Intervention: Drug: R-Pdf/Gbb 0.01% gel
9 Not yet recruiting Brexpiprazole (OPC 34712) Trial in the Treatment of Adults With Major Depressive Disorder and Irritability
Condition: Major Depressive Disorder and Irritability
Intervention: Drug: Brexpiprazole
10 Recruiting A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Patients With Multiple Myeloma Following Autologous Stem Cell Transplant
Conditions: Multiple Myeloma;   Autologous Stem Cell Transplant
Interventions: Drug: Ixazomib Citrate;   Drug: Placebo
11 Not yet recruiting Living Well on Androgen Deprivation Therapy
Condition: Prostate Cancer
Interventions: Behavioral: Exercise Sessions;   Behavioral: Nutrition Education;   Behavioral: Peer Support Volunteer
12 Recruiting Prospective Trial to Compare the Clinical Efficiency of G-EYE™ HD Colonoscopy With Standard HD Colonoscopy
Conditions: Adenoma;   Polyps;   Colorectal Cancer
Interventions: Device: G-EYE™ colonoscopy;   Device: Standard Colonoscopy
13 Recruiting Free Fatty Acids: Short Exposure Study
Condition: Hypogeusia
Interventions: Other: NEFA;   Other: Sucrose
14 Recruiting Study of Methemoglobin as a Biomarker of Tissue Hypoxia During Acute Hemodilution in Heart Surgery Patients
Condition: Other Functional Disturbances Following Cardiac Surgery
Intervention: Device: Brain Oximetry
15 Unknown  Personalized Medicine for Diabetes Prediction and Prevention of Complications
Conditions: Metabolic Syndrome;   Diabetes
Intervention: Other: Breath analysis and blood analysis
16 Recruiting PASCUAL (Prostate Assay Specific Clinical Utility at Launch) Study
Condition: Prostate Cancer
Intervention:
17 Not yet recruiting Correlation of the Arrhythmia Mechanism and Substrate to Ablate Persistent Atrial Fibrillation Study
Condition: Persistent Atrial Fibrillation
Intervention: Procedure: Catheter ablation
18 Recruiting Study Assessing Impact of Dermatology Consultation for Patients Admitted With Cellulitis
Condition: Cellulitis
Intervention: Other: Dermatology consult
19 Recruiting Safety and the Pharmacokinetic Study of Characteristics of MKT-N2 (Montelukast) and Singulair® (Montelukast Sodium)to Treat Asthma
Condition: Asthma and Allergic Rhinitis
Interventions: Drug: Montelukast;   Drug: Montelukast sodium
20 Recruiting A 26-Week Extension Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy
Conditions: Schizophrenia;   Impaired Cognition
Intervention: Drug: EVP-6124

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years